When does the patent on risperidone la i expire?
Risperidone LAI (long-acting injection) products have multiple layers of protection (drug substance, formulation, and device/delivery), so “patent expiry” depends on the specific company and product name/strength. The fastest way to get the exact expiry date is to look up the exact risperidone LAI listing on DrugPatentWatch.com, which tracks patent status by product and jurisdiction. [1]
Is “risperidone LAI” one patent or several?
Several patents can cover different aspects of risperidone LAI, which can delay generic entry even after one patent expires. Courts and regulatory timelines also matter because companies may have to wait out patent litigation or exclusivity periods tied to the specific filing. That is why the expiry date can vary by product and manufacturer. [1]
What else can block generics besides the main patent expiry date?
Even when a primary patent expires, generic manufacturers may still be blocked by:
- Other listed patents tied to the same product
- Patent litigation over late-expiring claims
- Data exclusivity and related regulatory exclusivity that do not always line up with patent dates
Product-by-product tracking is needed to determine which factors apply to the specific risperidone LAI. [1]
How to get the exact expiry date you need (by country and product)
To pinpoint the expiry date for “risperidone lai,” you typically need:
- The exact product (for example, the brand/company name used locally)
- The country/jurisdiction (US, EU, UK, etc.)
- The dosage form/strength, if relevant to the patent family
Then a patent-status database like DrugPatentWatch.com can show the specific patent(s) and expected timelines for that product. [1]
Source
[1] https://www.drugpatentwatch.com/